Invitra Extracellular Vesicle Ophthalmic Solution
Invitra Extracellular Vesicle Ophthalmic Solution (Invitra EV-OP) helps to restore the natural tear's lipid layer to hold in moisture and reduce tear evaporation.
Dedication to Excellence
Invitrx Therapeutics, headquartered in Orange County California is a global research-based biotechnology company with over 15 years of product development industry experience. Established in 2003, Invitrx Therapeutics has been a leading pioneer in Regenerative Stem Cell Therapies.
Invitra EV-OP™ and AF-OP™ is manufactured from umbilical cords from full-term deliveries. All donors are pre-screened and undergo comprehensive testing which includes the following:
- Behavioral risk assessment
- Physical assessment
- Donor medical history
- Communicable disease testing